Author:
Mar Javier,Moragues Carmen,Arrospide Arantzazu,de Agustín Juan José,Arman Albert,Montserrat Magda,Soler López Begoña
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference32 articles.
1. D’Ambrosia RD. Epidemiology of osteoarthritis. Orthopedics. 2005;28(2 Suppl):s201–5.
2. Hadorn DC. Setting priorities for waiting lists: defining our terms. Steering Committee of the Western Canada Waiting List Project. CMAJ. 2000;163:857–60.
3. Quintana JM, Escobar A, Arostegui I, Bilbao A, Azkarate J, Goenaga JI, Arenaza JC. Health-related quality of life and appropriateness of knee or hip joint replacement. Arch Intern Med. 2006;166:220–6.
4. Quintana JM, Arostegui I, Escobar A, Azkarate J, Goenaga JI, Lafuente I. Prevalence of knee and hip osteoarthritis and the appropriateness of joint replacement in an older population. Arch Intern Med. 2008;168:1576–84.
5. Carmona L, Ballina J, Gabriel R, Laffon A, EPISER Study Group. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis. 2001;60:1040–5.